Studying Depression at a Molecular Level


How do defective neuro-glia interactions contribute to depression?

Michal Slezak, PhD

A recent study suggests that alterations in astrocyte metabolism is a major hallmark of depression. In this Mental Health Minute, Michal Slezak, PhD, explains how he and other researchers used state-of-the-art imaging techniques and genetic approaches to identify molecular processes impaired in depression. The researchers propose that novel, glial-specific drugs could target the molecular mechanics of depression.

Dr Slezak is a group leader at BioMed X Institute studying brain microcircuits in psychiatric diseases.

Does addressing depression at the molecular level sound like a promising treatment to you? Share comments with your colleagues by emailing Comments may be shared online pending review and editing for style.

Related Videos
brain depression
brain schizophrenia
eating disorder brain
© 2024 MJH Life Sciences

All rights reserved.